Trial Profile
A phase I/II, randomized, double-blind, placebo-controlled study of the safety, tolerance, pharmacokinetics, and antiviral activity of 9-[2-(R)-[[bis[[(isopropoxycarbonyl)-oxy]methoxy]phosphinoyl]methoxy]propyl]adenine fumarate (PMPA prodrug) in HIV-infected patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 20 Oct 2005 New trial record.